This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Delayed milestone in childhood
R18_DELAY_MILES_CHILDH
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
680 |
4. Check minimum number of eventsNone |
680 |
5. Include endpointsNone |
680 |
6. Filter based on genotype QC (FinnGen only) |
680 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- R62
Similar endpoints
↥List of similar endpoints to
Delayed milestone in childhood
based on the number of shared cases.
Similar with more cases:
- Lack of expected normal physiological development
- General symptoms and signs
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 680 | 297 | 383 |
| Unadjusted period prevalence (%) | 0.14 | 0.10 | 0.17 |
| Median age at first event (years) | 2.82 | 2.50 | 3.08 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 605
- Matched controls
- 5492
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R62.0
ICD-10 Finland
Delayed milestone
+∞
323.0
606
40
F83
ICD-10 Finland
Mixed specific developmental disorders
14.8
101.1
184
157
XA800
NOMESCO Finland
Neuropsychological investigation
7.8
72.0
189
300
Z3226
NOMESCO Finland
Physiotherapist
4.6
62.7
305
993
F82
ICD-10 Finland
Specific developmental disorder of motor function
11.8
60.9
120
112
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
5.4
59.2
216
511
R4110
NOMESCO Finland
Physiotherapy
4.4
56.4
280
904
Z2445
NOMESCO Finland
Psychologist
5.0
53.2
205
506
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
6.5
51.5
150
263
RL140
NOMESCO Finland
NA
18.2
50.2
81
46
R4120
NOMESCO Finland
Occupational therapy
7.7
48.6
123
175
Z2446
NOMESCO Finland
Social worker
4.1
47.3
240
760
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.0
45.7
234
743
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
6.8
43.3
120
193
F80.1
ICD-10 Finland
Expressive language disorder
8.5
43.1
101
126
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
12.9
41.6
77
61
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.9
39.6
107
165
ZXE10
NOMESCO Finland
More than one and less than three hours
3.1
35.7
270
1116
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
8.6
35.7
82
98
RT150
NOMESCO Finland
NA
10.6
34.4
70
67
RL130
NOMESCO Finland
NA
11.5
32.9
64
56
Z31.5
ICD-10 Finland
Genetic counselling
5.1
32.2
113
238
Z2221
NOMESCO Finland
Medical doctor
3.1
32.1
244
993
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
31.6
248
1028
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
13.9
31.1
55
39
F80.2
ICD-10 Finland
Receptive language disorder
8.3
30.6
71
86
Z3231
NOMESCO Finland
Registered nurse
2.7
29.9
326
1644
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.1
27.9
191
709
Z50.5
ICD-10 Finland
Speech therapy
4.4
27.8
110
261
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.2
27.4
178
638
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.8
27.0
98
212
R4130
NOMESCO Finland
Speech therapy
6.4
27.0
75
118
Z3229
NOMESCO Finland
Other healthcare associate professional
3.5
25.6
141
441
ZXD10
NOMESCO Finland
Scheduled procedure
2.5
25.3
298
1521
N03AG01
ATC
valproic acid; systemic, rectal
5.1
24.4
82
163
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.7
23.7
116
331
602
Kela drug reimbursment
Children's severe malnutrition
5.0
23.4
80
162
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
22.8
140
473
RT490
NOMESCO Finland
NA
13.9
22.3
39
27
R1260
NOMESCO Finland
Evaluation of communicative skills
8.5
21.8
49
56
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.3
21.3
122
391
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
21.1
184
776
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
4.0
21.1
90
227
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.0
20.2
87
221
RS222
NOMESCO Finland
NA
7.3
19.4
48
64
H50.31
ICD-10 Finland
Intermittent exotropia
6.5
19.4
52
78
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.2
19.3
115
377
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
5.2
19.2
62
117
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
4.1
19.2
79
192
ZXE20
NOMESCO Finland
More than three and less than five hours
3.0
19.2
126
442
ZXE00
NOMESCO Finland
One hour or less
2.2
19.0
305
1726
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
18.6
209
998
P85
ICPC
Mental retardation
8.6
18.5
41
46
FM2CE
NOMESCO Finland
NA
3.2
18.5
110
359
RT160
NOMESCO Finland
NA
7.8
18.3
43
53
N03AX14
ATC
levetiracetam; systemic
5.2
18.2
59
112
N05BA09
ATC
clobazam; oral
6.5
17.9
48
72
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.9
17.6
118
419
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.3
17.5
97
301
RT190
NOMESCO Finland
NA
15.3
17.4
29
18
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
17.4
242
1271
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
17.4
175
785
N05CD08
ATC
midazolam; nasal, systemic
4.7
17.4
62
131
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
17.2
143
577
RD210
NOMESCO Finland
NA
3.4
17.1
90
269
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
7.1
16.8
42
57
H01AC01
ATC
somatropin; parenteral
4.6
16.8
61
131
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
5.4
16.8
52
94
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
16.7
133
523
H50.30
ICD-10 Finland
Intermittent esotropy
6.5
16.6
44
65
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
17.5
16.5
26
14
DFF20
NOMESCO Finland
Audiometry for children
4.5
15.8
58
126
183
Kela drug reimbursment
Lamotrigin and topiramate
7.3
15.6
38
50
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
19.6
15.2
23
11
TJD20
NOMESCO Finland
Change of gastrostomy tube
8.1
15.0
34
40
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.6
14.9
71
196
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.1
14.8
87
280
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.0
14.2
86
283
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
29.6
14.2
19
6
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
19.7
14.0
21
10
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.8
13.9
97
350
WX882
NOMESCO Finland
High dependency care
2.5
13.8
121
496
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.7
13.8
48
99
N03AX09
ATC
lamotrigine; oral
4.4
13.8
51
112
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
15.9
13.6
22
13
A28
ICPC
Limited function/disability NOS
3.2
13.2
73
225
H50.0
ICD-10 Finland
Convergent concomitant strabismus
5.7
13.1
38
64
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.9
13.0
85
292
TPH07
NOMESCO Finland
Cathetrisation of artery
2.7
13.0
96
358
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
9.1
12.9
27
28
RS220
NOMESCO Finland
NA
4.9
12.9
43
85
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.9
12.7
83
285
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.1
12.6
50
118
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
12.5
127
562
H52.2
ICD-10 Finland
Astigmatism
3.9
12.5
53
133
JDB10
NOMESCO Finland
Percutaneous gastrostomy
8.2
12.2
27
31
N05AX08
ATC
risperidone; systemic
3.5
11.9
57
158
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
22.6
11.9
17
7
ZXD05
NOMESCO Finland
Urgent procedure
2.1
11.8
160
803
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.2
11.7
63
191
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.1
11.7
67
212
RT130
NOMESCO Finland
NA
14.8
11.5
19
12
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.7
11.5
86
321
H52.0
ICD-10 Finland
Hypermetropia
3.4
11.5
56
158
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
6.7
11.5
29
41
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.0
11.4
68
219
DFF00
NOMESCO Finland
Pure tone audiometry
3.3
11.4
59
174
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.9
11.2
247
1483
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
6.2
11.2
30
46
XF600
NOMESCO Finland
Bloodpressure measurement
2.4
11.1
107
458
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.0
11.0
30
47
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
10.9
117
528
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
10.9
167
878
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
5.4
10.8
32
56
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.5
10.7
90
358
C03DA01
ATC
spironolactone; oral
4.2
10.6
40
90
E34.35
ICD-10 Finland
Abnormal growth retardation
3.4
10.6
52
147
WX722
NOMESCO Finland
PEEP
3.7
10.6
47
123
RS140
NOMESCO Finland
NA
8.9
10.6
22
23
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
6.8
10.5
26
36
R62.9
ICD-10 Finland
Lack of expected normal physiological development, unspecified
12.9
10.4
18
13
RS314
NOMESCO Finland
NA
12.9
10.4
18
13
XKD00
NOMESCO Finland
Uroflowmetry
3.5
10.4
49
135
H50.1
ICD-10 Finland
Divergent concomitant strabismus
8.0
10.3
23
27
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
8.6
10.3
22
24
F72.0
ICD-10 Finland
Severe mental retardation, with the statement of no, or minimal, impairment of behaviour
25.9
10.2
14
5
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.1
10.2
57
176
XX4AW
NOMESCO Finland
NA
3.5
10.1
47
128
RF120
NOMESCO Finland
NA
8.9
10.1
21
22
P94.2
ICD-10 Finland
Congenital hypotonia
30.0
9.9
13
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.2
9.8
51
151
Q93.8
ICD-10 Finland
Other deletions from the autosomes
17.4
9.7
15
8
H53.0
ICD-10 Finland
Amblyopia ex anopsia
3.8
9.6
40
99
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.5
9.6
45
123
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.3
9.4
88
372
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.8
9.4
61
208
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
4.6
9.4
32
66
N05BA01
ATC
diazepam; systemic, rectal
3.1
9.3
52
161
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
9.8
9.2
18
17
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.5
9.2
43
118
ZY010
NOMESCO Finland
Hospital outpatient
2.2
9.2
102
467
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
4.2
9.2
34
76
G40.89
ICD-10 Finland
Other epilepsy
8.1
9.2
20
23
205
Kela drug reimbursment
Chronic hypertension
4.3
9.1
33
72
ZX114
NOMESCO Finland
Intramuscular
4.4
9.1
32
68
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
13.9
9.0
15
10
181
Kela drug reimbursment
Retigabine and vigabatrin
8.4
8.9
19
21
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
4.4
8.8
31
66
DFF10
NOMESCO Finland
Measurement of acoustic impedance (tympanometry and reflex testing)
5.3
8.8
26
46
N03AX11
ATC
topiramate; oral
4.7
8.8
29
58
ZX199
NOMESCO Finland
Other rote
4.9
8.8
28
54
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
4.4
8.7
31
67
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.3
8.7
43
124
XF404
NOMESCO Finland
Ambulatory ECG
2.9
8.6
53
175
201
Kela drug reimbursment
Chronic cardiac insufficiency
4.8
8.6
28
55
K03.66
ICD-10 Finland
Tooth plaque
2.0
8.6
120
604
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
8.5
132
690
M41.4
ICD-10 Finland
Neuromuscular scoliosis
10.6
8.5
16
14
RS211
NOMESCO Finland
NA
4.5
8.5
29
60
WX730
NOMESCO Finland
Conventional respirator
5.3
8.5
25
44
B01AA03
ATC
warfarin; systemic
4.9
8.5
27
52
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
8.5
133
699
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.8
8.5
53
179
WX002
NOMESCO Finland
Sedation and analgesia
2.4
8.3
73
296
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
7.4
8.3
19
24
N03AG04
ATC
vigabatrin; oral
7.4
8.3
19
24
N03AF02
ATC
oxcarbazepine; oral
3.2
8.2
43
129
RT274
NOMESCO Finland
NA
8.8
8.2
17
18
R62
ICD-10 Finland
Lack of expected normal physiological development
82.7
8.1
9
*
RS142
NOMESCO Finland
NA
10.7
8.1
15
13
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.2
8.1
42
126
RF420
NOMESCO Finland
NA
11.8
7.9
14
11
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
6.8
7.9
19
26
P07.3
ICD-10 Finland
Other preterm infants
2.8
7.9
51
177
C03CA01
ATC
furosemide; systemic
3.4
7.8
37
103
ZXA10
NOMESCO Finland
Bilateral
1.9
7.8
118
609
P07.2
ICD-10 Finland
Extreme immaturity
7.9
7.8
17
20
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
8.7
7.8
16
17
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
13.3
7.8
13
9
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.6
7.7
55
200
Q21.10
ICD-10 Finland
Persistent ostium secundum
3.2
7.7
40
120
301
Kela drug reimbursment
Growth hormone
4.5
7.7
26
54
J96.1
ICD-10 Finland
Chronic respiratory failure
15.8
7.7
12
7
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.0
7.6
44
141
R1250
NOMESCO Finland
Evaluation of functional capability
4.7
7.6
25
50
H47.2
ICD-10 Finland
Optic atrophy
10.8
7.6
14
12
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.1
7.5
28
64
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.4
7.5
35
97
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
7.5
105
528
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.2
7.4
27
60
Q75.3
ICD-10 Finland
Macrocephaly
12.0
7.4
13
10
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
3.2
7.4
37
108
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.2
7.4
37
108
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
41.3
7.4
9
*
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
2.6
7.4
53
193
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.4
7.4
63
255
ZXD20
NOMESCO Finland
Day surgery
2.3
7.3
70
299
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.7
7.3
48
168
R5599
NOMESCO Finland
Other rehabilitation service
3.2
7.3
37
109
F79
ICD-10 Finland
Unspecified mental retardation
13.8
7.3
12
8
WX402
NOMESCO Finland
General anaesthesia
1.8
7.3
147
836
101
Kela drug reimbursment
Anterior pituitary hypofunction
3.6
7.3
31
80
H47.7
ICD-10 Finland
Disorder of visual pathways, unspecified
23.0
7.2
10
*
N03AF03
ATC
rufinamide; oral
16.9
7.2
11
6
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
4.8
7.2
23
45
SPAT1229
SPAT
Assessment of need for aid
5.0
7.2
22
41
ZX108
NOMESCO Finland
Inhalation
4.5
7.1
24
50
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
3.4
7.0
33
92
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
3.3
7.0
34
97
WX892
NOMESCO Finland
Monitored bed care
2.2
7.0
68
293
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.7
7.0
45
156
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.6
6.9
51
190
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
5.0
6.9
21
39
UDC00
NOMESCO Finland
Ear microscopy
2.3
6.9
66
280
NF1DA
NOMESCO Finland
X-ray of hips
6.0
6.9
18
28
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
10.0
6.9
13
12
Q04.8
ICD-10 Finland
Other specified congenital malformations of brain
14.5
6.8
11
7
F88
ICD-10 Finland
Other disorders of psychological development
4.0
6.8
26
61
ZX120
NOMESCO Finland
Intravenous
2.2
6.8
68
294
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.5
6.8
23
48
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
3.5
6.8
30
80
R2110
NOMESCO Finland
Giving the first information
3.2
6.8
34
100
XF622
NOMESCO Finland
Measurement of minute volume of heart
6.3
6.8
17
25
A11CC03
ATC
alfacalcidol; systemic
3.6
6.7
29
76
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
6.7
415
3166
TJF80
NOMESCO Finland
Ostomy education
4.8
6.6
21
41
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
4.8
6.6
21
41
A41.9
ICD-10 Finland
Sepsis, unspecified
3.1
6.6
35
107
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
7.3
6.6
15
19
H02AB09
ATC
hydrocortisone; systemic
2.5
6.6
52
201
ZXA00
NOMESCO Finland
Right side
2.0
6.6
89
437
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.4
6.6
30
82
UKC02
NOMESCO Finland
Cystoscopy
3.4
6.6
30
82
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
4.0
6.5
25
59
XG413
NOMESCO Finland
Spirometry with oscillometry
3.0
6.5
37
117
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
6.4
6.5
16
23
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
6.9
6.4
15
20
C08CA05
ATC
nifedipine; systemic
15.3
6.4
10
6
RD160
NOMESCO Finland
NA
7.6
6.4
14
17
NFL22
NOMESCO Finland
Myotomy or tenotomy of hip or thigh
20.7
6.4
9
*
199
Kela drug reimbursment
Rufinamide
20.7
6.4
9
*
Q38.1
ICD-10 Finland
Ankyloglossia
3.2
6.3
32
95
EJC20
NOMESCO Finland
Operation on frenulum in mouth
3.7
6.3
26
66
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.3
6.3
58
244
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.6
6.3
27
71
H66.9
ICD-10 Finland
Otitis media, unspecified
1.6
6.2
182
1149
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
64.2
6.2
7
*
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
7.2
6.2
14
18
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
7.2
6.2
14
18
F84.8
ICD-10 Finland
Other pervasive developmental disorders
5.9
6.1
16
25
UGC02
NOMESCO Finland
Rigid bronchoscopy
4.3
6.1
21
45
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
6.0
35
114
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
4.2
6.0
21
46
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
401
2316
2.40
26.34
24.0
15.3
mmol/l
1.2
1.2
0.38
390
2225
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
407
2382
2.38
25.68
21.1
14.3
mmol/l
1.2
1.2
0.60
388
2238
(3014111) Lactate [Moles/volume] in Serum or Plasma
132
519
2.62
19.39
17.0
17.4
mmol/l
1.4
1.4
0.11
120
466
(3003458) Phosphate [Moles/volume] in Serum or Plasma
232
1177
2.19
19.15
15.5
12.1
mmol/l
1.4
1.4
0.11
223
1127
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
31
45
6.48
18.01
1.1
1.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
239
1273
2.08
17.02
10.8
11.0
kpa
5.4
5.2
0.47
230
1248
(3021447) Carbon dioxide [Partial pressure] in Venous blood
244
1323
2.05
16.45
10.9
11.2
kpa
5.8
5.7
0.35
235
1296
(3002032) Base excess in Venous blood by calculation
242
1319
2.03
15.99
11.0
11.2
mmol/l
1.0
1.1
0.08
195
1026
(3049233) Organic acids panel - Urine
28
42
6.25
15.77
1.2
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
225
1203
2.04
15.61
18.2
11.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
156
725
2.23
15.56
17.7
14.8
mmol/l
0.8
0.8
0.77
151
697
(3022313) Gas panel - Capillary blood
225
1211
2.02
15.26
18.9
10.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
229
1241
2.01
15.24
10.9
10.4
mmol/l
23.7
23.6
0.35
223
1211
(3019550) Sodium [Moles/volume] in Serum or Plasma
566
4221
2.33
14.70
24.1
14.3
mmol/l
139.4
139.3
0.41
560
4104
(3023103) Potassium [Moles/volume] in Serum or Plasma
564
4218
2.29
14.22
23.9
14.3
mmol/l
4.0
4.0
3.77
554
4075
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
372
2453
1.83
12.99
7.7
5.8
u/l
154.9
138.4
2.19
355
2320
(3013336) Amino acids [Identifier] in Serum or Plasma
34
74
4.32
12.77
2.7
2.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
169
877
1.99
12.33
4.6
4.3
ph
7.4
7.4
1.10
22
138
(3015377) Calcium [Moles/volume] in Serum or Plasma
189
1023
1.93
12.18
3.2
3.1
mmol/l
2.4
2.4
0.25
177
932
(3024561) Albumin [Mass/volume] in Serum or Plasma
241
1421
1.83
11.85
11.5
9.9
g/l
37.7
37.9
0.20
232
1355
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
220
1264
1.85
11.73
19.4
9.5
mmol/l
23.9
24.0
0.19
220
1259
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
231
1356
1.82
11.44
19.8
10.2
mmol/l
0.9
0.8
0.29
179
980
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
231
1358
1.82
11.38
19.8
10.3
kpa
5.1
5.0
0.88
226
1317
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
563
4323
2.08
11.29
12.3
9.5
u/l
28.5
26.4
0.72
554
4184
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
253
1542
1.78
10.96
11.7
9.5
umol/l
27.8
27.8
0.00
232
1416
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
287
1818
1.75
10.84
5.4
3.8
nmol/l
72.2
68.5
1.56
282
1730
(3028626) Oxygen [Partial pressure] in Capillary blood
218
1276
1.81
10.79
20.0
9.9
kpa
9.5
9.8
1.11
212
1238
(3023368) Bacteria identified in Blood by Culture
152
795
1.94
10.68
4.2
4.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
210
1230
1.79
10.28
4.3
3.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
62
235
2.53
9.61
10.3
7.0
ng/l
196.9
231.7
0.22
56
214
(3052851) Hemolysis interference index of Serum or Plasma
51
177
2.74
9.41
2.9
4.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
365
2540
1.65
9.20
13.5
9.0
mmol/l
5.7
6.1
3.03
351
2380
(40758558) Short blood count panel - Blood
286
1870
1.67
9.19
10.1
9.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
66
264
2.40
9.13
1.8
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
256
1632
1.68
9.03
6.9
4.6
e6/l
10.9
33.2
3.22
202
1242
(3007853) Bacteria identified in Skin by Aerobe culture
129
675
1.90
8.93
2.4
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
65
262
2.38
8.84
26.6
17.6
mmol/l
-0.7
-0.2
0.47
50
217
(3009214) Lutropin [Units/volume] in Serum or Plasma
91
423
2.09
8.79
2.7
2.4
u/l
5.2
5.3
0.05
58
256
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
262
1690
1.66
8.77
7.2
4.9
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
82
372
2.13
8.42
2.8
2.4
iu/l
6.5
5.9
0.18
51
233
(3026782) Osmolality of Urine
179
1052
1.73
8.42
5.3
3.5
mosm/kgh2o
564.2
600.8
1.11
161
919
(1175426) CD3 cells/100 lymphocytes in Blood
49
179
2.59
8.20
3.6
4.1
%
63.6
67.9
0.53
49
179
(36304419) Bacteria [Presence] in Urine
241
1545
1.64
8.13
7.0
4.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
179
1064
1.71
8.04
5.4
3.7
e6/l
6.6
5.7
0.43
163
932
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
179
1070
1.70
7.85
4.3
3.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
49
183
2.53
7.85
3.6
4.1
e9/l
1.5
1.5
0.20
38
128
(3004789) Transferrin [Mass/volume] in Serum or Plasma
122
655
1.84
7.73
4.8
3.3
g/l
2.5
2.6
0.72
117
630
(3032080) INR in Blood by Coagulation assay
158
916
1.73
7.73
7.3
4.9
inr
1.1
1.1
0.06
25
230
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
46
168
2.59
7.71
34.0
22.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
47
175
2.54
7.58
3.7
4.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
237
1536
1.61
7.53
7.2
4.4
e6/l
0.2
0.2
0.10
185
1146
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
47
176
2.52
7.49
3.3
3.9
e6/l
561.4
549.5
0.05
38
126
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
115
615
1.83
7.36
9.2
8.9
umol/l
6.4
6.6
0.07
96
509
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
47
178
2.49
7.32
3.3
3.9
e9/l
0.2
0.2
0.06
38
128
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
45
168
2.53
7.22
3.5
4.1
%
22.9
26.2
0.95
45
168
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
165
991
1.67
7.02
5.4
3.8
e6/l
0.7
0.8
0.09
102
567
(40761511) CBC panel - Blood by Automated count
584
4742
1.86
6.92
14.1
8.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
45
172
2.46
6.89
2.3
2.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
167
1013
1.65
6.82
5.3
3.9
e6/l
2.7
1.9
0.35
106
595
(3020630) Protein [Mass/volume] in Serum or Plasma
44
168
2.47
6.75
3.3
4.3
g/l
63.8
63.0
0.19
44
161
(3000060) B lymphocytes [#/volume] in Blood
45
177
2.39
6.49
3.7
4.1
e6/l
397.1
382.1
0.06
35
119
(3027945) Reticulocytes/100 erythrocytes in Blood
132
769
1.69
6.24
7.2
7.2
%
1.5
1.4
0.57
127
736
(3018095) Leukocytes [#/volume] in Urine
273
1891
1.51
6.18
8.4
5.5
e6/l
19.6
51.3
2.33
205
1282
(3032641) Amino acids panel - Urine
15
31
4.45
6.03
1.0
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
47
195
2.27
6.02
34.9
19.6
%
94.7
95.9
0.47
47
195
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
125
725
1.69
5.99
5.8
5.8
mg/l
3.3
1.8
1.02
102
508
(3013931) Oligosaccharides [Presence] in Urine
10
8
11.46
5.73
1.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
13
25
4.78
5.66
2.9
2.6
umol/l
21.5
18.1
0.28
13
25
(3019832) Treponema pallidum Ab [Presence] in Serum
51
862
0.50
5.54
1.7
1.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
28
95
2.74
5.45
3.5
5.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
46
198
2.18
5.42
35.5
19.3
%
0.7
0.7
0.07
46
198
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
41
169
2.27
5.35
2.1
2.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
49
218
2.11
5.32
2.4
2.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
26
87
2.77
5.20
3.5
5.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
89
489
1.75
5.17
2.4
2.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
20
58
3.18
5.10
2.0
1.7
nmol/l
19.4
18.6
—
9
20
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
11
20
5.04
5.08
1.6
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
127
2.42
5.03
29.9
25.9
u/ml
0.3
0.3
0.09
22
87
(3002385) Erythrocyte distribution width [Ratio]
579
4789
1.67
5.02
25.1
16.6
%
13.4
13.1
5.57
571
4723
(3021960) Folate [Moles/volume] in Serum or Plasma
85
472
1.72
4.76
1.5
1.3
nmol/l
21.1
18.8
0.69
79
411
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
33
131
2.34
4.71
5.5
5.9
ug/l
2.6
2.1
0.53
33
131
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
45
204
2.07
4.68
12.2
12.3
iu/ml
311.6
534.2
—
8
31
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
48
223
2.02
4.67
2.6
2.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
432
3391
1.43
4.53
4.1
3.4
pmol/l
14.5
14.5
0.17
405
3109
(3017446) Testosterone [Moles/volume] in Serum or Plasma
69
366
1.79
4.52
2.9
2.2
nmol/l
7.7
10.5
1.71
56
283
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
18
54
3.07
4.37
7.9
8.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
143
926
1.50
4.23
3.7
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
227
1610
1.42
4.17
5.2
4.7
—
—
—
0
0
(44806118)
40
182
2.05
4.14
2.3
2.5
—
—
—
0
0
(44790048)
40
182
2.05
4.14
2.3
2.5
—
—
—
0
0
(44790049)
40
182
2.05
4.14
2.3
2.5
—
—
—
0
0
(44790047)
40
182
2.05
4.14
2.3
2.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
37
164
2.10
4.10
2.4
2.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
475
3823
1.42
4.09
4.3
3.7
mu/l
2.2
2.0
1.49
455
3608
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
25
94
2.46
4.03
13.3
10.1
mg/l
9.8
9.4
0.14
25
86
(3009508) Creatinine [Moles/volume] in Urine
169
1142
1.45
4.03
4.9
5.2
mmol/l
7.2
8.5
1.97
162
1077
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
100
1301
0.64
4.02
2.6
2.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
72
402
1.69
3.96
1.7
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
85
496
1.63
3.96
2.5
2.1
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
23
84
2.53
3.94
4.3
4.0
%
5.0
1.8
—
10
35
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
84
493
1.62
3.82
2.6
2.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
12
30
3.67
3.81
14.2
14.3
nmol/l
637.8
687.7
0.14
12
30
(3007461) Platelets [#/volume] in Blood
644
5564
2.06
3.78
26.5
17.0
e9/l
270.9
272.9
0.28
621
5275
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
90
540
1.59
3.74
6.3
3.7
ng/l
937.4
1437.4
0.91
67
305
(3013650) Neutrophils [#/volume] in Blood by Automated count
414
3281
1.37
3.72
14.4
12.1
e9/l
3.6
3.4
1.05
366
2694
(3011397) Hemoglobin [Presence] in Urine by Test strip
169
1162
1.42
3.63
4.4
3.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
644
5572
2.03
3.62
26.4
16.8
fl
85.3
85.5
0.44
638
5497
(3035941) MCH [Entitic mass]
644
5573
2.02
3.60
26.4
16.8
pg
28.7
28.8
0.70
638
5499
(4035726)
49
252
1.82
3.58
2.2
1.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
644
5574
2.02
3.58
26.4
16.8
e12/l
4.6
4.7
0.88
617
5270
(3006315) Basophils [#/volume] in Blood
390
3072
1.35
3.58
11.8
10.2
e9/l
0.0
0.0
0.09
339
2511
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
39
186
1.95
3.58
15.6
14.2
u/ml
412.4
1078.3
—
5
26
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
47
239
1.84
3.56
1.8
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
47
239
1.84
3.56
1.8
1.4
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
31
136
2.11
3.55
4.0
5.0
umol/l
22.1
24.8
1.33
31
136
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
10
23
3.98
3.54
1.5
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
644
5577
2.01
3.52
27.8
17.2
g/l
131.9
133.5
1.84
639
5507
(3001604) Monocytes [#/volume] in Blood
390
3077
1.35
3.51
11.8
10.2
e9/l
0.6
0.6
3.48
337
2517
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
32
143
2.08
3.50
2.8
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
644
5579
2.00
3.48
26.5
16.9
e9/l
7.1
7.0
0.24
620
5283
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
54
289
1.75
3.47
1.5
1.4
pmol/l
539.3
25379271.2
0.50
48
264
(3024891) Influenza virus A+B Ag [Presence] in Specimen
60
331
1.70
3.47
1.7
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
90
550
1.55
3.46
4.9
5.1
e9/l
69.0
61.0
1.04
65
335
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
125
819
1.47
3.46
2.5
3.5
u/l
56.5
56.5
0.00
117
765
(3021589) Normoblasts [#/volume] in Blood
375
2945
1.34
3.46
13.0
11.8
e9/l
0.0
0.0
0.50
302
2212
(3020393) Adenovirus Ag [Presence] in Stool
33
150
2.04
3.46
2.7
1.8
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
23
90
2.36
3.44
1.8
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
59
325
1.70
3.43
7.2
9.0
g/l
0.3
0.4
0.72
45
276
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
15
47
2.93
3.41
2.3
1.4
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
20
74
2.49
3.36
8.3
8.3
mg/l
2.2
2.2
0.02
14
65
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
23
91
2.33
3.36
5.1
5.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
56
306
1.72
3.35
1.7
1.9
mmol/l
2.4
2.4
0.23
46
246
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
14
43
2.99
3.30
2.4
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
126
835
1.45
3.29
1.8
1.6
pmol/l
96.9
98.8
0.19
67
429
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
18
64
2.59
3.28
6.0
7.3
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
18
64
2.59
3.28
6.7
7.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
97
1221
0.67
3.26
2.3
2.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
101
642
1.50
3.25
7.4
3.8
g/l
8.1
8.9
1.36
101
618
(3044290) Cell count panel - Cerebral spinal fluid
38
187
1.89
3.21
2.7
5.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
27
118
2.11
3.15
5.3
4.0
mmol/l
92.0
83.6
0.32
22
109
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
570
4819
1.45
3.07
18.7
11.5
mg/l
23.1
24.2
0.37
435
3236
(3042733) HLA Ab [Presence] in Serum
17
61
2.56
3.05
3.7
3.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
539
5178
0.71
3.02
3.8
3.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
395
3163
1.31
2.99
13.1
11.2
e9/l
0.2
0.2
0.00
350
2638
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
31
146
1.97
2.98
3.1
4.1
ml/min/173m2
95.0
93.3
—
6
41
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
96
616
1.48
2.95
2.7
2.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
24
104
2.13
2.87
2.7
1.9
g/l
1.1
1.1
0.15
18
89
(3003338) MCHC [Mass/volume]
583
4965
1.46
2.86
24.9
15.8
g/l
335.4
335.7
0.30
577
4912
(3037467) Urinalysis macro (dipstick) panel - Urine
353
2798
1.30
2.81
6.7
4.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
109
727
1.43
2.74
1.9
2.0
mmol/l
1.2
1.2
0.18
103
666
(3031040) Bacteria [#/volume] in Urine by Automated count
333
2631
1.29
2.67
6.3
3.8
e6/l
318.8
177.2
—
10
31
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
16
60
2.45
2.65
4.1
5.3
ug/l
24.1
25.9
0.18
16
60
(3019198) Lymphocytes [#/volume] in Blood
394
3182
1.29
2.65
11.8
10.0
e9/l
2.5
2.5
0.53
350
2685
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
22
3.74
2.61
1.4
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
232
2469
0.77
2.58
2.0
2.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
311
2443
1.28
2.58
12.3
10.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
27
128
1.95
2.58
1.6
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
374
3007
1.28
2.57
11.8
10.3
%
3.1
3.4
1.06
360
2888
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
20
356
0.49
2.57
1.4
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
115
1350
0.72
2.55
2.1
2.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
367
2946
1.28
2.55
11.9
10.4
%
0.6
0.6
1.27
354
2844
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
18
73
2.26
2.54
9.8
9.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
35
182
1.78
2.53
2.5
2.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
32
163
1.81
2.48
2.3
2.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
19
3.84
2.43
1.8
2.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
278
2167
1.27
2.41
5.9
5.0
u/l
31.0
27.6
0.98
271
2087
(3019225) pH of Specimen
30
152
1.82
2.37
7.2
5.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
37
200
1.71
2.36
2.7
5.2
e6/l
228.9
1090.2
0.71
30
141
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
37
200
1.71
2.36
2.7
5.2
e6/l
33.4
8.9
0.35
30
137
(3015736) pH of Urine
206
1550
1.29
2.35
4.3
3.5
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
6
11
4.97
2.35
2.3
2.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
273
0.45
2.34
1.1
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
27
133
1.87
2.33
1.8
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
157
0.34
2.31
1.3
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
29
147
1.82
2.29
1.3
1.4
ug/g
345.5
390.5
0.59
21
68
(3019069) Monocytes/100 leukocytes in Blood
374
3032
1.26
2.29
11.9
10.4
%
8.5
8.4
0.39
361
2918
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
171
1260
1.31
2.28
3.1
3.5
mg/l
2.8
2.6
0.79
156
1139
(3008757) Leukocyte morphology finding [Identifier] in Blood
27
134
1.86
2.28
2.1
5.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
26
128
1.87
2.25
6.0
5.2
u/ml
45.6
25.6
0.27
26
123
(3019060) Gas panel - Arterial blood
17
72
2.17
2.19
6.3
11.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
29
150
1.78
2.16
10.5
26.7
%
72.2
72.0
0.03
29
150
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
73
2.14
2.12
1.1
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
16
67
2.19
2.12
2.6
2.4
ug/l
1.9
1.7
—
9
34
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
68
2.16
2.05
1.1
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
317
2543
1.24
2.05
2.8
2.1
mmol/l
5.3
5.4
0.46
300
2311
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
22
106
1.91
2.04
3.6
2.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
45
267
1.56
2.04
4.6
5.4
%
1.0
0.3
0.68
16
68
(3002030) Lymphocytes/100 leukocytes in Blood
386
3166
1.24
2.03
11.7
10.1
%
35.9
36.6
0.55
372
3056
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
282
2236
1.24
2.02
4.2
3.2
mmol/mol
34.5
36.5
3.15
266
2124
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
34
2.69
2.01
1.9
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
36
203
1.64
2.00
9.6
11.4
mmol/l
23.2
22.9
0.19
36
191
(3020891) Body temperature
20
94
1.95
2.00
7.3
8.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
207
0.43
1.98
1.2
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
29
2.83
1.98
1.0
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
379
3108
1.24
1.97
11.5
9.9
%
47.8
47.8
0.01
367
3003
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
101
1.91
1.97
1.9
1.8
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
8
24
3.04
1.95
2.4
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
40
234
1.58
1.93
2.1
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
48
293
1.52
1.93
5.9
6.0
%
1.4
0.5
0.72
19
98
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
32
177
1.67
1.92
3.3
2.9
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
30
164
1.69
1.88
3.0
6.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
15
3.64
1.85
1.0
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
15
3.64
1.85
1.7
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
15
3.64
1.85
1.7
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
15
3.64
1.85
1.7
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
15
3.64
1.85
1.7
1.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
45
274
1.52
1.84
5.9
6.2
%
0.1
0.0
0.36
19
93
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
31
2.65
1.83
1.6
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
31
2.65
1.83
1.6
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
31
2.65
1.83
1.6
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
245
1930
1.23
1.83
4.5
3.6
estimate
0.0
0.0
0.00
34
303
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
10
36
2.54
1.82
3.0
2.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
34
194
1.62
1.82
2.2
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
21
105
1.84
1.77
1.8
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
244
1928
1.23
1.76
6.9
5.3
estimate
0.0
0.0
0.00
40
334
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
24
126
1.75
1.74
2.5
2.3
mmol/l
2.6
1.9
0.56
16
100
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
243
0.51
1.73
1.7
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
49
2.24
1.71
1.3
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
64
774
0.72
1.70
2.3
2.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
5
12
3.79
1.67
1.2
1.8
mu/l
1319.7
85.3
—
5
12
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
12
3.79
1.67
1.2
1.4
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
28
156
1.65
1.66
5.1
7.4
g/mol
143.9
414.0
0.41
22
146
(40768804) Tissue Pathology biopsy report
120
880
1.28
1.65
1.7
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
56
2.12
1.64
1.5
2.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
173
0.46
1.64
1.6
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
28
157
1.64
1.63
10.3
26.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
23
2.77
1.60
1.7
2.2
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
44
276
1.47
1.59
1.0
1.0
kpa
3.5
3.3
0.31
37
231
(3012441) Differential panel - Pleural fluid
5
13
3.50
1.56
1.0
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
243
1939
1.21
1.56
4.6
3.6
estimate
0.0
0.0
0.00
38
325
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
88
1001
0.76
1.55
1.8
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
55
667
0.72
1.50
1.8
2.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
33
2.49
1.49
1.2
1.2
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
44
280
1.45
1.49
1.0
1.0
mmol/l
-1.3
-2.2
—
7
61
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
44
280
1.45
1.49
1.0
1.0
kpa
6.9
7.3
0.69
37
234
(3006598) pH of Arterial cord blood
44
280
1.45
1.49
1.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
55
666
0.72
1.49
1.7
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
55
665
0.73
1.48
1.6
2.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
286
0.59
1.47
1.9
1.8
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
25
2.55
1.46
1.6
2.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
35
2.34
1.44
2.7
1.9
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
11
47
2.14
1.43
3.3
7.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
28
163
1.58
1.43
4.9
4.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
279
2270
1.19
1.42
9.1
6.3
ml/min/173m2
114.2
113.0
0.36
182
1455
(3000764) Benzodiazepines [Presence] in Urine
55
660
0.73
1.41
1.6
2.1
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
55
369
1.38
1.41
1.0
1.0
mu/l
8.3
8.8
0.25
48
322
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
73
1.88
1.40
1.1
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
55
658
0.73
1.39
1.6
2.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
5
15
3.03
1.37
4.2
3.6
%
13.2
11.6
—
5
15
(21494814) CD8 cells/100 lymphocytes in Specimen
5
15
3.03
1.37
4.2
3.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
66
767
0.75
1.37
2.0
1.7
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
15
75
1.83
1.31
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
75
1.83
1.31
1.8
1.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
42
519
0.71
1.30
1.2
1.2
u/ml
2.7
1.0
0.42
28
389
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
11
49
2.05
1.30
3.3
7.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
30
182
1.51
1.30
3.5
3.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
42
273
1.42
1.30
6.0
6.1
%
0.0
0.0
0.00
19
81
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
10
43
2.12
1.29
1.8
1.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
10
43
2.12
1.29
1.8
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
10
43
2.12
1.29
1.8
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
12
56
1.96
1.27
2.1
2.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
15
76
1.80
1.26
3.9
2.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
53
626
0.75
1.24
1.6
2.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
17
2.67
1.22
1.4
2.5
mmol/l
4.1
3.9
—
5
17
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
23
2.37
1.21
1.8
2.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
23
2.37
1.21
2.8
7.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
34
2.14
1.19
3.8
6.0
ug/l
216.9
209.4
—
8
34
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
385
0.69
1.17
1.4
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
30
0.00
1.17
0.0
1.3
—
4.4
—
0
5
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
30
0.00
1.17
0.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
16
85
1.72
1.17
2.0
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
15
224
0.60
1.17
1.3
1.3
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
8
35
2.08
1.16
1.6
1.1
mu/l
474.9
454.4
—
8
35
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
33
0.00
1.15
0.0
1.2
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
5
18
2.52
1.15
6.2
3.8
mmol/l
4.4
4.7
—
5
18
(3003888) Timothy IgE Ab [Units/volume] in Serum
44
527
0.74
1.14
1.2
1.2
u/ml
5.1
6.3
0.23
34
411
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
25
151
1.52
1.13
1.8
1.2
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
8
36
2.02
1.12
1.6
1.1
%
67.9
75.3
—
8
36
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
12
59
1.86
1.11
1.2
2.8
nmol/l
3.5
3.0
0.10
12
52
(3011648) Oxygen content in Venous blood
20
115
1.59
1.11
11.9
32.8
%
12.0
11.5
0.34
20
115
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
73
532
1.27
1.09
2.5
2.2
ng/l
53.5
53.7
0.00
40
191
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
14
73
1.75
1.09
1.6
1.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
5
19
2.39
1.08
4.6
3.3
e9/l
0.3
0.3
—
5
19
(21494434) Karyotype in Bone marrow
13
67
1.77
1.05
1.5
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
95
1.64
1.05
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
136
0.53
1.05
2.0
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
276
2289
1.15
1.04
4.4
3.4
ug/l
52.1
56.1
0.25
267
2174
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
48
558
0.76
1.03
1.3
1.2
u/ml
3.4
2.9
0.09
34
383
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
20
2.27
1.02
1.4
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
20
2.27
1.02
1.2
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
31
2.05
1.02
1.3
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
31
201
1.41
1.01
1.3
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
32
1.99
0.98
4.9
3.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
13
69
1.72
0.97
1.2
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
13
69
1.72
0.97
1.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
179
0.60
0.96
1.4
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
179
0.60
0.96
1.5
1.6
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
44
511
0.76
0.95
1.1
1.2
u/ml
4.7
4.4
0.04
14
182
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
24
2.27
0.94
2.0
1.9
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
88
672
1.21
0.90
1.6
1.5
u/ml
170.1
373.9
1.40
83
637
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
36
425
0.75
0.88
1.4
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
42
294
1.31
0.88
1.1
1.2
—
13.8
—
0
5
(1001926) Buprenorphine [Presence] in Urine by Screen method
46
523
0.78
0.86
1.6
2.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
65
1.68
0.85
1.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
41
1.77
0.84
1.8
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
42
1.73
0.82
1.8
1.3
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
21
134
1.43
0.77
1.8
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
26
173
1.37
0.77
1.3
1.2
—
—
—
0
0
(3022670) pH of Venous cord blood
11
60
1.67
0.77
1.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
15
90
1.52
0.74
1.1
1.0
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
6
98
0.55
0.73
1.7
1.5
—
250.0
—
0
6
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
61
1.64
0.73
1.5
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
9
51
1.60
0.72
1.2
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
30
207
1.33
0.72
1.6
1.5
nmol/l
1295.0
1012.0
0.99
24
164
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
33
231
1.31
0.72
3.7
2.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
36
1.77
0.71
2.4
2.7
u/ml
1556.6
1268.7
—
7
36
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
71
752
0.84
0.71
1.1
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
20
129
1.42
0.71
7.3
8.1
—
—
—
0
0
(4268621)
9
52
1.57
0.70
4.6
2.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
107
0.59
0.69
6.1
4.3
e9/l
2.2
3.1
—
7
107
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
70
1.56
0.67
1.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
22
147
1.37
0.65
3.0
2.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
10
56
1.62
0.65
2.3
1.4
ug/l
0.5
0.8
—
10
50
(3014133) Dog dander IgE Ab [Units/volume] in Serum
27
314
0.77
0.63
1.1
1.1
u/ml
10.3
8.2
0.15
15
191
(3021879) Hepatitis B virus core Ab [Presence] in Serum
35
393
0.80
0.63
1.3
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
11
149
0.66
0.63
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
149
0.66
0.63
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
149
0.66
0.63
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
11
149
0.66
0.63
1.5
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
69
723
0.85
0.62
2.4
1.8
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
64
1.56
0.62
1.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
43
319
1.23
0.61
3.4
2.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
5
27
1.68
0.61
1.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
27
1.68
0.61
1.0
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
5
27
1.68
0.61
1.2
1.1
u/l
1297.6
230.1
—
5
22
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
27
1.68
0.61
1.0
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
68
712
0.85
0.61
1.6
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
19
0.00
0.60
0.0
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
31
1.76
0.58
1.5
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
31
1.76
0.58
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
31
1.76
0.58
1.5
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
14
88
1.45
0.58
1.8
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
58
1.57
0.58
1.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
33
1.65
0.56
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
34
1.60
0.55
1.5
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
34
1.60
0.55
1.5
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
108
1082
0.88
0.54
2.9
3.5
ug/g
185.5
98.5
0.58
89
878
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
35
1.56
0.53
1.5
2.7
pg
34.7
31.9
—
6
35
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
121
1.36
0.53
1.2
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
41
309
1.21
0.52
1.2
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
9
57
1.43
0.52
3.2
2.9
ug/l
0.9
2.0
—
9
49
(3009542) Hematocrit [Volume Fraction] of Blood
577
5122
1.13
0.52
26.6
16.0
%
38.5
39.4
3.05
529
4676
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
13
83
1.43
0.51
4.2
4.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
13
83
1.43
0.51
4.2
4.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
32
236
1.24
0.50
1.2
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
14
91
1.40
0.50
1.2
1.3
—
38.9
—
0
8
(3025018) Bordetella pertussis Ab [Titer] in Serum
27
196
1.26
0.48
1.3
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
197
1671
1.09
0.47
2.3
2.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
107
0.67
0.46
1.4
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
21
239
0.79
0.45
1.3
1.1
—
—
—
0
0
(4306422)
10
62
1.47
0.45
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
281
2427
1.08
0.44
3.8
2.7
mmol/l
1.2
1.1
1.23
273
2310
(3029937) Albumin [Presence] in Urine by Test strip
109
901
1.11
0.44
4.6
3.8
estimate
0.0
0.0
0.00
39
314
(3016018) Differential panel - Cerebral spinal fluid
19
134
1.29
0.43
3.2
4.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
28
1.62
0.43
1.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
180
1528
1.09
0.43
1.6
1.6
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
8
51
1.42
0.42
6.3
4.9
mmol/l
1.2
1.6
—
8
51
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
29
1.56
0.42
3.4
1.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
53
1.37
0.41
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
235
2233
0.93
0.41
1.6
1.9
u/ml
1.5
4.3
2.12
36
367
(40768441) Liver Pathology biopsy report
11
72
1.39
0.39
2.0
2.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
299
2599
1.07
0.39
4.0
2.9
mmol/l
4.2
4.3
1.70
293
2478
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
32
1.42
0.39
1.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
18
204
0.79
0.38
1.4
2.6
nmol/l
1.5
0.4
1.26
18
177
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
37
388
0.85
0.37
1.4
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
33
1.37
0.37
1.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
33
1.37
0.37
1.2
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
33
1.37
0.37
1.0
1.1
—
—
—
0
0
(44813793)
8
102
0.71
0.37
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
62
1.32
0.37
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
62
1.32
0.37
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
63
1.30
0.37
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
63
1.30
0.37
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
63
1.30
0.37
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
63
1.30
0.37
1.2
1.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
32
246
1.19
0.36
1.1
1.5
u/ml
1.0
3.7
1.74
25
182
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
121
0.74
0.34
1.3
2.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
42
1.30
0.33
1.2
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
15
169
0.80
0.32
1.0
1.1
u/ml
1.1
8.6
—
5
52
(3011897) Casein IgE Ab [Units/volume] in Serum
14
159
0.79
0.31
1.1
1.7
—
8.0
—
0
46
(3001019) Free T4 and TSH panel - Serum or Plasma
10
119
0.76
0.31
1.1
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
95
926
0.92
0.31
8.4
5.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
48
1.32
0.31
1.4
1.7
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
26
200
1.18
0.30
1.2
1.1
iu/ml
5.4
7.1
—
6
29
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
15
167
0.81
0.29
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
42
426
0.88
0.29
1.5
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
21
159
1.20
0.29
1.4
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
20
151
1.20
0.28
1.4
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
109
0.74
0.27
9.8
4.5
%
41.1
49.0
—
9
109
(1616796) Gas panel - Central venous blood
15
110
1.24
0.27
8.7
6.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
69
1.32
0.27
1.2
1.1
—
—
—
0
0
(4027681)
8
59
1.23
0.27
1.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
42
423
0.89
0.26
1.3
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
26
271
0.86
0.26
1.1
1.1
u/ml
3.1
0.4
—
8
140
(3023430) Cat dander IgE Ab [Units/volume] in Serum
28
290
0.87
0.26
1.1
1.1
u/ml
7.7
10.8
0.35
16
186
(4062490)
16
119
1.22
0.26
1.7
1.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
12
86
1.27
0.26
12.3
8.8
kpa
5.2
4.8
1.29
12
86
(3027315) Oxygen [Partial pressure] in Blood
12
86
1.27
0.26
12.3
8.3
kpa
8.9
9.6
0.45
12
86
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
15
111
1.23
0.25
1.2
1.3
u/ml
4.3
6.6
0.52
15
100
(3012516) Albumin [Mass/volume] in Urine
49
402
1.11
0.25
3.4
3.9
mg/l
165.8
174.1
0.04
38
321
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
79
1.26
0.23
1.3
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
34
1.33
0.23
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
34
1.33
0.23
1.0
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
66
643
0.92
0.23
1.2
1.2
—
3.0
—
0
5
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
35
1.29
0.23
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
35
1.29
0.23
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
44
437
0.90
0.23
2.1
2.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
13
96
1.23
0.23
3.8
3.7
%
16.8
18.0
—
7
68
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
248
0.87
0.23
1.3
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
5
36
1.26
0.22
1.0
1.1
—
43.7
—
0
6
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
14
105
1.21
0.22
3.3
2.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
64
538
1.08
0.22
1.7
1.5
%
1.4
1.4
0.00
57
487
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
38
1.19
0.21
1.0
1.1
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
11
0.00
0.21
0.0
4.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
13
97
1.22
0.21
1.0
1.0
g/l
1.5
1.4
0.47
13
91
(40768797) Stomach Pathology biopsy report
39
321
1.11
0.20
1.7
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
20
157
1.16
0.20
1.4
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.20
0.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
44
1.24
0.20
1.3
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
244
2146
1.04
0.20
2.0
1.7
g/l
1.4
1.5
0.18
130
1078
(3011841) English Walnut IgE Ab [Units/volume] in Serum
10
111
0.81
0.20
1.2
1.3
u/ml
2.3
14.6
—
10
102
(3028433) Virus identified in Specimen by Culture
6
46
1.18
0.19
1.2
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
46
1.18
0.19
3.0
2.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
54
1.17
0.18
2.6
2.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
43
421
0.92
0.18
1.3
1.1
u/ml
21.2
6.3
0.32
13
115
(3003740) Influenza virus B Ag [Presence] in Specimen
25
202
1.12
0.18
1.8
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
119
0.83
0.17
1.5
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
185
1.13
0.17
1.7
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
49
412
1.08
0.17
1.4
1.3
iu/ml
71.8
141.5
0.90
13
122
(1002224) Polysomnography panel
5
62
0.73
0.17
1.0
1.1
—
—
—
0
0
(4010399)
22
223
0.89
0.17
1.4
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
25
203
1.12
0.16
1.8
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
118
0.84
0.16
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
118
0.84
0.16
1.5
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
64
1.13
0.16
2.4
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
30
297
0.91
0.16
6.2
4.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
71
0.76
0.15
1.3
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
70
1.17
0.15
12.7
10.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
12
92
1.18
0.15
1.7
2.7
—
—
—
0
0
(4198724)
12
92
1.18
0.15
1.3
2.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
73
1.12
0.15
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
84
1.19
0.14
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
183
0.89
0.14
1.2
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
27
223
1.10
0.14
1.6
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
22
220
0.90
0.14
1.6
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
87
0.83
0.14
1.6
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
23
229
0.91
0.13
2.1
1.5
g/l
1.0
1.1
1.24
23
222
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
45
383
1.07
0.12
2.6
2.7
u/l
22.8
30.3
1.51
40
307
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
23
227
0.91
0.12
2.1
1.5
g/l
0.2
0.2
1.02
23
221
(3013512) EKG study
55
473
1.06
0.11
2.5
2.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
16
161
0.90
0.11
1.4
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
72
626
1.05
0.10
1.8
1.6
titre
177.8
524.3
—
9
93
(3019150) Specific gravity of Urine by Refractometry
98
915
0.96
0.10
3.7
3.3
kg/l
1.0
1.0
0.05
18
178
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
39
1.16
0.10
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
36
344
0.94
0.09
1.9
1.9
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
48
1.13
0.09
1.8
7.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
79
1.15
0.09
1.7
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
101
889
1.03
0.09
3.8
3.2
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
6
51
1.06
0.08
1.2
1.1
u/ml
3.1
1.7
—
6
43
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
59
1.07
0.08
1.3
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
60
1.06
0.08
1.6
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
106
1.11
0.08
2.3
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
139
0.91
0.07
1.2
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
48
452
0.96
0.07
1.3
1.2
iu/ml
14.1
13.7
—
10
93
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
68
1.07
0.07
2.3
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
20
194
0.93
0.07
1.5
2.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
76
0.83
0.07
1.0
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
286
2561
1.02
0.07
4.0
2.7
mmol/l
2.5
2.6
1.10
277
2407
(3013707) Erythrocyte sedimentation rate by Westergren method
332
2978
1.02
0.06
6.0
4.5
mm/h
7.6
7.2
0.39
321
2769
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
176
1571
1.02
0.06
2.0
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
47
412
1.03
0.05
3.7
2.5
u/l
4483.8
6379.8
0.26
13
132
(3034770) Mitochondria Ab [Titer] in Serum
16
135
1.07
0.05
2.3
2.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
91
1.10
0.04
1.2
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
44
410
0.97
0.04
3.0
2.1
u/ml
181.9
160.7
0.24
27
184
(3014599) Egg white IgE Ab [Units/volume] in Serum
27
234
1.05
0.04
1.3
1.5
u/ml
2.0
10.8
1.33
20
168
(3020682) Albumin/Creatinine [Ratio] in Urine
45
397
1.03
0.03
4.3
4.5
mg/mmol
20.9
50.4
0.39
35
318
(3022145) Colonoscopy Study observation
24
225
0.96
0.02
2.0
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
143
0.95
0.02
3.1
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
282
2539
1.01
0.02
3.9
2.7
mmol/l
1.3
1.4
2.00
273
2403
(3000492) Spirometry study
36
319
1.02
0.01
1.4
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
247
1.03
0.01
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
94
1.06
0.01
1.1
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
16
150
0.96
0.00
1.1
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
109
981
1.01
0.00
1.2
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
11
100
1.00
0.00
3.5
2.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
27
246
0.99
0.00
1.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
20
183
0.99
0.00
1.2
1.2
u/ml
0.2
2.4
—
5
59
(3028707) Methadone [Presence] in Urine by Screen method
35
314
1.01
0.00
1.9
2.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
46
413
1.01
0.00
2.9
2.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
36
325
1.00
0.00
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
10
86
1.05
0.00
1.0
1.5
u/l
39.9
39.1
—
10
81
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
138
1244
1.00
0.00
4.2
3.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
105
1.03
0.00
1.3
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
12
105
1.03
0.00
1.3
1.3
%
72.1
73.6
0.04
12
105
(3020961) Endomysium IgA Ab [Titer] in Serum
82
746
0.99
0.00
1.3
1.4
—
155.2
—
0
32
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
34
304
1.01
0.00
2.3
1.9
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
17.7
—
0
7
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
9
85
0.96
0.00
1.1
1.2
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4038314)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
194.3
—
0
9
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
3.1
—
0
6
(3042631) Mycobacterium sp identified in Specimen
0
8
0.00
0.00
0.0
16.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
51
0.89
0.00
1.2
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
89
0.91
0.00
1.6
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
89
0.91
0.00
3.6
2.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
47
0.96
0.00
1.4
3.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
63
1.01
0.00
2.6
2.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
5
47
0.96
0.00
1.2
1.4
umol/l
12.8
8.3
—
5
47
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4034850)
7
70
0.90
0.00
6.0
5.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
70
0.90
0.00
1.1
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
26.6
—
0
8
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
3.0
—
4.0
—
0
5
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
3.4
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
23.6
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
3.4
—
12.4
—
0
5
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_DELAY_MILES_CHILDH – Delayed milestone in childhood
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).